Outsourcing is not new in the life sciences sector. Clinical research outsourcing, contract sales forces and contract manufacturing have been a way of doing business since the 1980s. However, functional outsourcing in R&D, where individual processes or functions are outsourced, came later than in other industries.

Friday, Nov 01, 2015: Outsourcing is not new in the life sciences sector. Clinical research outsourcing, contract sales forces and contract manufacturing have been a way of doing business since the 1980s. However, functional outsourcing in R&D, where individual processes or functions are outsourced, came later than in other industries.

This conservative approach was driven by concerns around intellectual property protection as well as regulatory accountability. The sector is increasingly embracing the functional outsource model as confidence grows in its ability to deliver benefits in cost, capacity, and capability.

Cost, as in other industries, is one driver of outsourcing. The increase in regulatory requirements as well as the increasing complexity of R&D programmes mean R&D functions are faced with an increasing workload to be managed within the same or lower budgets. In Navitas’ experience working with life sciences companies, most with R&D centres based in high-cost geographies generate, at most, 5-10 per cent of cost savings from outsourcing to service providers based in similar locations. The key change to the model was “offshore outsourcing” or outsourcing processes to low-cost geographies, namely India, which delivers cost savings of more than 25 per cent – mainly due to the lower cost of personnel. Cost savings remain an important, but not the only, reason for outsourcing.

A number of Navitas’ clients have looked to outsourcing as a solution for the increasing requirement of flexibility in resource capacity. Many functions within R&D – clinical development, pharmacovigilance, regulatory affairs and medical affairs – are staffed with highly skilled, high-cost scientific personnel. Workloads in these functions fluctuate and are also difficult to forecast with certainty. Outsourcing provides a way of managing such resource requirements, with the service providers ramping the team up and down dynamically across multiple clients. In many such arrangements, the service provider has a core team which becomes an extension of the client’s internal team and fluctuations are managed through a floating pool.

In recent years, as workload requirements in R&D functions have increased, specific functions have faced a shortage of skilled scientific personnel. In the three functions that Navitas provides services in – clinical, regulatory and safety – there are specific processes where there is a continuing shortage of experienced personnel, such as biostatisticians, statistical programmers, regulatory writers, labelling specialists, pharmacovigilance specialists, and so on. In the absence of experienced personnel, companies are increasingly outsourcing these functions to service providers. The service providers in effect operate training academies in these functions, bringing in people with the right educational qualifications, training them and providing them with relevant experience under the guidance of more senior people.

Functional outsourcing is now an established way of doing business for most life sciences companies. As outsourcing service providers have gained experience in partnership with sponsor companies, many are looking for innovations within the delivery models. Navitas is among a small group of life sciences-focused service providers who combine capabilities in outsourcing, technology and consulting to cross-fertilise innovation. Specifically, this has resulted in “process outsourcing enhanced by technology”, where process outsourcing is combined with technology innovations within the process to enhance the efficiencies delivered to the sponsor.

Author:

  Shalabh Kumar
Global Head of Services,
Navitas

 

Click here to read the original post

 

Latest News

20
Apr2017

ICH Reflection on “GCP Renovation”: Modernization of ICH E8 and...

Navitas welcomes the opportunity to provide comments on this Reflection Paper... Navitas welcomes the opportunity...

13
Apr2017

Navitas Life Sciences Augments Global Executive Management Team

Navitas Life Sciences announced the appointment of Dr. Krishnan Rajagopalan as Chief Growth Officer....

24
Jan2017

Navitas Networks announce Forum dates for Spring, 2017

The Navitas Networks are pleased to confirm the dates for our upcoming Spring forums... ...

17
Jan2017

Navitas Launches Labeling Assessment Express

Regulators are changing the way they look at labeling. The emphasis is on ensuring...

02
Nov2016

BioVectra chooses pharmaREADY for eCTD Solution

BioVectra has chosen pharmaREADY for its eCTD requirements. BioVectra, located in Canada, manufactures...

05
Oct2016

Navitas at DIA's 10th Annual Forum for Qualified Persons...

Navitas Principal Jeffrey Ho will present "Efficient content management for the compilation and...

04
Oct2016

News 2016

[row id="1" class="ROW_CLASS"] [col class="span12"] 02 Nov 2016 AbbVie and Navitas Present Case Study on the Evolution...

27
Sep2016

Navitas releases paper on CDISC, the standards and why the...

The FDA (and eventually, regulatory agencies from around the world) will require clinical data...

13
Sep2016

AbbVie and Navitas Present Case Study on the Evolution and...

At 10:30a.m. (East Coast Time) on September 22nd, Navitas and AbbVie will...

29
Jul2016

Navitas Networks announce Forum dates for Autumn, 2016

The Navitas Networks are pleased to confirm the dates for our upcoming Autumn forums....

12
Jul2016

Navitas Celebrates 100th pharmaREADY customer

pharmaREADY is Navitas’ intuitive and easy to use, fully integrated, regulatory compliant, web-based suite...

28
Jun2016

Navitas' PVTech Summit Defines Future Success

Navitas’ PVTech Summit was held on June 15th at the Hudson Hotel in New...

18
May2016

Navitas Welcomes Tara Baer to Navitas

Navitas is pleased to welcome Tara Baer, who joins Navitas' Regulatory Practice. With over...

18
May2016

Navitas Speaks at Sparta Connection in Orlando

David Gwyn, Navitas' Technology Practice lead, will unveil idmpREADY at the Sparta Connection conference...

14
Mar2016

Navitas Earns Speaking Sessions at DIA’s 52nd Annual Meeting

In two different sessions, Subject Matter Experts from Navitas will address new challenges facing...

09
Mar2016

Navitas is pleased to announce the introduction of our networks...

Navitas' inaugural pvindia meeting took place in Mumbai on Thursday 03 March, 2016. ...

25
Jan2016

Navitas Announces the Inaugural pvindia Forum

Navitas will soon be adding to our portfolio of industry leading networks with the...

18
Jan2016

Navitas Relaunches pharmaREADY.com

pharmaREADY.com is Navitas' next generation website for its fully integrated, regulatory compliant document management,...

14
Dec2015

Steve Arlington, Navitas Advisor, Spoke on the Challenges, Opportunities and...

Steve Arlington, Navitas Advisor, Spoke on the Challenges, Opportunities and Future of the Pharmaceutical...

03
Nov2015

The changing trends in drivers of life sciences R D...

Outsourcing is not new in the life sciences sector. Clinical research outsourcing, contract sales...